The results consider survey responses fielded in October from 536 U.S. consumers between the ages of 26 and 64.
Here are three additional findings from the survey.
1. Seventy-nine percent of respondents would consider genetic testing, or pharmacogenomics, to lower potential drug side effect risks.
2. When asked, “If you were offered free genetic testing to limit the risk of drug side effects, would you want to get this testing now, whether or [not] you are currently on medications?” respondents answered the following:
- Yes 49 percent
- Considering 30 percent
- Not sure 13 percent
- No 8 percent
3. Thirty-three percent of respondents had undergone genetic testing. Of those tested, 52 percent found the results useful, according to the survey.
More articles on supply chain:
6 medical groups to Congress: We need a ‘comprehensive strategy’ for critical drug shortages
AHA urges FDA to address saline bag shortage
5 recent pharma layoffs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
